8 February 2017
At PMI, we are committed to the transparent advancement of our science to develop reduced-risk alternatives to cigarettes. As part of that effort, we are proud to announce our first Reduced-Risk Product (RRP) Scientific Update - a regular publication dedicated to showcasing our research efforts on a range of potentially reduced-risk alternatives to cigarettes.
This update, addressed to scientists, regulators and others, provides a summary of PMI’s product development and assessment approach, as well as an overview of our latest studies, key peer-reviewed publications and presentations at scientific conferences. In addition, we detail our two ambulatory reduced exposure studies on Platform 1 and explain their relevance to our overall assessment program.
As Prof. Manuel Peitsch, our Chief Scientific Officer, explains: “We are making significant efforts to develop and scientifically assess innovative products that generate a vapor in which harmful chemicals found in cigarette smoke are significantly reduced or eliminated, while the taste, sensory experience and ritual characteristics of smoking are preserved as much as possible. Along with many public health experts, we believe innovative products backed up by solid science can play an important role to reduce the harm of smoking. Sharing our methodologies and findings allows feedback and review from external experts and regulators and can encourage further research in the field.”
An important factor of this update is to complement our ongoing efforts to share our latest science. We encourage those who are interested in learning more to explore this website, and follow us on our social media platforms @pmiscience.